This topic contains a solution. Click here to go to the answer

Author Question: The therapist is about to institute NPPV on a patient who is experiencing respiratory distress. At ... (Read 69 times)

Sufayan.ah

  • Hero Member
  • *****
  • Posts: 512
The therapist is about to institute NPPV on a patient who is experiencing respiratory distress. At the same time, the therapist would like for this patient to verbally communicate when possible. Which of the following interfaces would most likely accommodate this form of communication?
 
  A. oronasal
  B. helmet
  C. mouthpiece
  D. nasal

Question 2

The therapist is providing bilevel NPPV, and is using an HME for humidification. The therapist observes that the patient is having difficulty triggering and cycling inspiration. Which of the following actions should the therapist take at this time?
 
  A. Remove the HME.
  B. Increase the IPAP.
  C. Decrease the EPAP.
  D. Adjust the trigger sensitivity setting.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

isabelt_18

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

ANS: D

Answer to Question 2

ANS: B





 

Did you know?

People often find it difficult to accept the idea that bacteria can be beneficial and improve health. Lactic acid bacteria are good, and when eaten, these bacteria improve health and increase longevity. These bacteria included in foods such as yogurt.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library